Skip to content
10-K

Annual Report

COLUCID PHARMACEUTICALS, INC.

0001564590-16-015194

← back to feed
Filed
Mar 24, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Mar 23, 2016 15.27M sh
Cash And Equivalents FY 2015 · Dec 31, 2015 $27.98M
Cash And Equivalents FY 2015 · Dec 31, 2014 $204.36K
Cash And Equivalents FY 2015 · Dec 31, 2013 $333K
Stockholders Equity FY 2015 · Dec 31, 2015 $58.41M
Stockholders Equity FY 2015 · Dec 31, 2014 −$1.79M
Stockholders Equity FY 2015 · Dec 31, 2013 −$9.91M
Current Liabilities FY 2015 · Dec 31, 2015 $5.43M
Current Liabilities FY 2015 · Dec 31, 2014 $581.55K
Total Liabilities FY 2015 · Dec 31, 2015 $6.93M
Total Liabilities FY 2015 · Dec 31, 2014 $2.08M
Current Assets FY 2015 · Dec 31, 2015 $65.32M
Current Assets FY 2015 · Dec 31, 2014 $227.07K
Total Assets FY 2015 · Dec 31, 2015 $65.34M
Total Assets FY 2015 · Dec 31, 2014 $293.25K
Sga Expense FY 2015 · Dec 31, 2015 $8.64M
Sga Expense FY 2015 · Dec 31, 2014 $1.14M
Rd Expense FY 2015 · Dec 31, 2015 $22.24M
Rd Expense FY 2015 · Dec 31, 2014 $1.17M
Net Income FY 2015 · Dec 31, 2015 −$30.74M
Net Income FY 2015 · Dec 31, 2014 −$2.95M
Operating Income FY 2015 · Dec 31, 2015 −$30.88M
Operating Income FY 2015 · Dec 31, 2014 −$2.31M